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Abstract 
Purpose: To determine the effect of phlomisoside F (PMF) on the proliferation, migration and invasion 
of human non-small cell lung cancer cell line A549 and explore the possible mechanisms. 
Methods: The anti-proliferative effect of PMF on A549 cells was determined by CCK-8. Subsequently, 
migration and invasion were evaluated by Transwell and Transwell with matrigel assays, respectively. 
Furthermore, cell cycle and apoptosis were assessed by flow cytometry, while the mechanisms of action 
were determined by Western blotting. 
Results: PMF exhibited significant anti-proliferative effect on A549 cells in concentration-dependent 
and time-dependent manners, with half maximal inhibitory concentration (IC50) of 54.51 µM. Treatment 
with PMF (10, 20 and 40 µM) for 48 h resulted in significantly decreased migration and invasion in A549 
cells. In addition, PMF at concentrations of 25, 50 and 75 µM induced cell cycle arrest in G0/G1phase 
and enhanced cell apoptosis in A549 cells. Furthermore, caspase-3, caspase-9 and Bax protein 
expressions were up-regulated while Bacl-2 and COX-2 protein expressions were significantly down-
regulated at 10, 20 and 40 µM concentrations of PMF. 
Conclusion: PMF suppresses A549 cell growth, migration and invasion. The mechanism may be 
related to the induction of mitochondria-mediated apoptosis pathway via regulation of caspase-3, 
caspase-9, Bcl-2 and Bax expressions, and inhibition of PGE2 synthesis by reducing COX-2 expression. 
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Lung cancer is the most common cancer in 
males with increasing incidence and mortality, 
and is the leading cause of cancer-related deaths 
in China [1]. Scientific data has clearly shown 
that the dominant risk factor of lung cancer is 
tobacco exposure and approximately 60 - 70 % 
of lung cancer patients are ever-smokers in 
China [2]. In addition, the most common type of 
lung cancer is non-small cell lung cancer 
(NSCLC) which has high rates of unknown 
disease stage at diagnosis [3]. Although 
researchers have made progress in the 
treatment of lung cancer, current treatment 
modalities are still inadequate and there is no 
cure. Therefore, an effective therapeutic method 
is still urgently needed to reduce the incidence 
and improve the survival of Chinese lung cancer 
patients. 
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Phlomis younghusbandii Mukerjee (Lamiaceae) 
is a perennial herbal plant, which is often found 
in the grassland of hillsides, meadows and river-
beaches in Qinghai-Tibet Plateau [4]. 
Importantly, the aerial part of this plant has been 
used as a kind of Tibetan conventional medicine 
for thousands of years in China [5]. P. 
younghusbandii has been widely used in clinical 
treatment and has various pharmacological 
activities, such as treating lung disease, colds 
and coughs, bronchitis and throat disease [5,6]. 
However, research and study on modern 
pharmacology of P. younghusbandii is not 
common. Over the years, several studies 
demonstrated that the root extracts of P. 
younghusbandii had anti-bacterial, analgesic and 
anti-inflammatory activities [7-9]. But whether the 
extracts or chemical components from Phlomis 
younghusbandii have anti-cancer activity has not 
been reported up to now. 
 
Phlomisoside F (PMF), a furanolabdane 
diterpene glycoside, is from the ethyl acetate 
extract of P. younghusbandii root, which has 
been reported in previous studies [10,11]. 
Previous data indicated that PMF has significant 
anti-inflammatory activity in vitro and in vivo [10]. 
In this study, PMF was isolated and identified 
from P. younghusbandii. Furthermore, the anti-
lung cancer activity of PMF was investigated and 
the possible mechanism was explored in A549 
cells, which may provide a scientific basis for its 




Preparation of pure compounds 
 
P. younghusbandii was procured from Hehuachi 
Market of Traditional Chinese Herbs in 2014 and 
identified by a taxonomist at the Department of 
Traditional Chinese Medicine of our hospital. A 
voucher specimen of P. younghusbandii 
(201408-LL) was kept in our laboratory for future 
reference. PMF was isolated from the dry root of 
P. younghusbandii and characterized by a 
previously described method [11]. In brief, the 
dry root of P. younghusbandii (10 kg) was 
pulverized to prepare the extract. After reflux 
extraction with ethanol two times for 2 h each 
time, the extract was filtered and then the solvent 
was evaporated to get the ethanol extract of P. 
younghusbandii root under reduced pressure in a 
rotary evaporator. Further, the crude ethanol 
extract was dissolved in distilled water and then 
the suspension was successively treated with 
petroleum ether, ethyl acetate and n-butanol. 
Thereafter, five fractions (I – V) were obtained by 
using silica gel (200 – 300 mesh) column 
chromatography and eluting with 
trichloromethane – methyl alcohol (8:1). Finally, 
the compound was isolated from fraction III by 
using repeated silica gel column chromatography 
(200 – 300 mesh) and Sephadex LH - 20 
chromatography. Additionally, the isolated 
compound, phlomisoside F, was identified based 
on the 1H-NMR and 13C-NMR data, which was 
consistent with previous data [11]. The chemical 
structure of PMF is shown in Figure 1. 
 
 
Figure 1: Chemical structure of phlomisoside F 
 
Cell culture  
 
Human non-small cell lung cancer cell line A549 
was purchased from Shanghai cell bank of 
Chinese Academy of Sciences (Shanghai, 
China) and cultured in RPMI – 1640 medium 
(Hyclone, Logan, UT) supplemented with 10 % 
fetal bovine serum (FBS; Gibco, Grand Island, 
USA) and antibiotics (100 U/mL penicillin G and 
100 mg/mL of streptomycin) at 37 °C in a 5 % 
CO2 humidified atmosphere. 
 
Cell proliferation assay by CCK-8 
 
Cellular proliferation was evaluated by Cell 
Counting Kit-8 (Beyotime, Jiangsu, China) 
following the manufacturer’s protocol. In brief, 2 
× 103 cells per well were seeded in 96-well plates 
and incubated with either vehicle (DMSO) or 
increasing concentrations of PMF. Cell 
proliferation was measured 48 h later and the 
absorbance was measured using a 96-well plate 
reader (Bio-Rad Laboratories, Shanghai, USA) at 
450 nm. Results were reported as a percentage 
of DMSO control cells. IC50 values represent the 
concentration at which cell growth was inhibited 
by 50 %. Furthermore, for determining the time-
dependent manner, A549 cells were treated with 
PMF (50 μM) for 12, 24, 36, 48 and 72 h, 
respectively; CCK–8 assay was used to 
determine cell proliferation inhibition. 
 
Cell cycle analysis and apoptosis assay by 
flow cytometry 
 
For cell cycle analysis, cells were cultured with 
either diluent control (DMSO) or various 
concentrations of PMF (25, 50 and 75 µM) for 48 
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h, and then were treated with 0.25 % trypsin to 
prepare the single cell suspension in phosphate 
buffered saline with 10 % FBS. After that, cells 
were washed and fixed in 70 % precooled 
ethanol. Finally, cells were stained by propidium 
iodide (PI)/RNase A and measured by flow 
cytometry (FACS Calibur, BD Biosciences). 
 
Annexin V - FITC Apoptosis Detection Kit 
(Beyotime, Jiangsu, China) was used to 
determine the effect of PMF on A549 cells 
apoptosis. After treatment with or without various 
concentrations of PMF (25, 50 and 75 µM) for 48 
h, cells were harvested and then were stained by 
annexin-V-fluorescein isothiocyanate (FITC) and 
PI according to the manufacturer’s protocol. 
Subsequently, the apoptotic cells were measured 
on a FACS Calibur Flow Cytometer (BD 
Biosciences, San Jose, CA, USA). The cells 
apoptosis in early was only labeled by annexin - 
V while the cells apoptosis in late was labeled by 
both annexin-V and PI.  
 
In vitro invasion and migration assay 
 
Cell invasion abilities were assessed by transwell 
well culture chambers (Corning Incorporated 
Tewksbury, MA, USA) with matrigel (BD 
Biosciences, Shanghai, China). In brief, the lower 
chamber was filled with 0.75 mL of RPMI 1640 
with 10 % FBS. Then 0.5 mL of A549 cells with 
serum-free RPMI 1640 (1 × 105 cells/well) were 
seeded in the upper chamber and treated with or 
without indicated PMF (10, 20 and 40 µM). After 
incubation for 48 h at 37 °C in 5 % CO2 
atmosphere, the invaded cell was stained with 
hematoxylin-eosin solution and counted by the 
optical microscope (Olympus, Japan). 
 
For transwell migration assay, the lower 
chambers were filed with RPMI 1640 medium 
with 10 % FBS and 5 × 104 cells with serum-free 
RPMI 1640 medium were seeded in the upper 
chamber with a non-coated transwell insert. And 
the subsequent steps were similar with the 
invasion experiment above. The migrated cells in 
the lower chamber were also stained with 
hematoxylin-eosin solution and observed by the 




Cells were harvested after treatment with various 
concentrations of PMF (10, 20 and 40 µM) for 48 
h. Subsequently, cells were lysed by western blot 
& IP cell lysis buffer (Beyotime, Jiangsu, China) 
and then the total protein was quantified by the 
BCA Protein Assay Reagent (Sangon Biotech, 
Shanghai, China).Equal amounts of protein (20 
µg) was loaded to the sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) 
and transferred to nitrocellulose filter membrane. 
Then, the membrane was incubated with anti-
caspase-3 (1: 200), anti-caspase-9 (1: 200), anti-
Bcl-2 (1: 200), anti-Bax (1: 200), anti-COX-2 (1: 
200) and anti-GAPDH (1: 200) antibodies at 4 °C 
for 12 h followed by corresponding horseradish 
peroxidase-conjugated secondary antibodies. 
Finally the immunoreactive band was visualized 
with ECL-detecting reagents. The primary 
antibodies included rabbit caspase-3polyclonal 
antibody, rabbit caspase-9 polyclonal antibody, 
rabbit Bcl-2 polyclonal antibody, rabbit Bax 
polyclonal antibody, rabbit COX-2polyclonal 
antibody, and rabbit GAPDH polyclonal antibody, 
which were purchased from Santa Cruz 
Biotechnologies (Santa Cruz, CA).The secondary 
antibody was horseradish peroxidase-conjugated 
goat anti-rabbit IgG and was purchased from 





All Data was expressed as mean ± standard 
deviation of three independent experiments and 
p < 0.05 was considered statistically significant. 
Data analysis was carried out using SPSS 19.0 
software package and one way analysis of 
variance (ANOVA) with Dunnett’s test was used 




PMF inhibits proliferation of A549 cell in vitro 
 
The effect of PMF on A549 cell viability was 
detected by the CCK-8 assay. As shown in 
Figure 2A, the estimated IC50 of PMF was 54.51 
µM in A549 cells. Compared with the vehicle 
group (DMSO group), PMF induced significant 
growth inhibition in concentration-dependent and 
time-dependent manners in 48 h (Figure 2B). 
 
PMF inhibits invasion and migration of A549 
cell in vitro 
 
We confirmed the inhibitory effect of PMF on 
A549 cells invasion and migration by the matrigel 
invasion assay and the transwell migration assay 
in vitro, respectively. Fig. 3A and B showed the 
effect of PMF on A549 cells invasion and there is 
a significant difference between the control and 
PMF treated groups (p < 0.01). Furthermore, as 
shown in Figure 3C and D, PMF at 10, 20 and 40 
µM also effectively inhibited lung cancer cell 
migration (p < 0.01). 
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Figure 2: Effect of PMF on the growth of A549 cells. (A) After treatment with either vehicle (DMSO, negative 
control) or increasing concentrations of PMF (0, 5, 10, 20, 40, 80 and 160 μM, 48 h), cell proliferation was 
determined by CCK-8 assay. Concentration-response curve was plotted to determine IC50 values using the 
GraphPad Prism 5. (B) Cells were treated with PMF (50 μM) and cell viability was analysed by CCK-8 assay at 0, 
12, 24, 36, 48 or 72 h Time-dependent curve was plotted to analyse the observed effect of PMF. Results 




Figure 3: Effect of PMF on cell invasion (A and B) and migration (C and D) in A549 cell. Cell invasion and 
migration of A549 cells with PMF (10, 20 and 40 μM, 48 h) vs DMSO control were analysed by transwell with 
matrigel and transwell migration assay, respectively. Results are expressed as means ± SD of three independent 
experiments in triplicates; **p < 0.01, compared to the control group 
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PMF induces cell cycle arrest and apoptosis 
in A549 cells 
 
To investigate whether the anti-proliferative effect 
of PMF is due to cell cycle arrest and/or 
apoptosis, we measured the effect of PMF on 
cell cycle progression and apoptotic response in 
A549 cell lines. Cells were treated with either 
increasing concentrations of PMF (25, 50 and 75 
µM) or vehicle control (DMSO) for 48 h and cell 
cycle distributions were determined by PI 
staining and flow cytometry. Upon incubation 
with PMF, A549 cells showed a dose-dependent 
accumulation in G0/G1, indicating cell cycle 
arrest in this phase (Figure 4A and B). 
 
Apoptotic response was determined by both 
annexin V and PI staining and flow cytometry in 
A549 cells. After 48 h exposure to PMF, the cell 
apoptosis rate was increased from 21.16 % to 
51.93 % with increasing concentrations of PMF 
(25, 50 and 75 µM), compared with the control 
group (Figure 5A and B). 
 
 
Figure 4: Effect of PMF on cell cycle of A549 cells. Results are expressed as mean ± SD (n = 3); **p < 0.01, 
compared to the control group. 
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Figure 5: Effects of PMF on cell apoptosis of A549 cells. Results are expressed as mean ± SD (n = 3);**p < 0.01, 
compared to the control group 
 
Protein expression levels of caspase-3, 
caspase-9, Bcl-2, Bax and COX-2 
 
Based on the results above, PMF inhibited the 
proliferation, migration and invasion of A549 cells 
and induced cell cycle arrest and apoptosis. To 
further explore the possible mechanisms, related 
proteins were detected by western blotting. As 
shown in Figure 6, it is interesting that the protein 
expression levels of caspase-3, caspase-9, and 
Bax were significantly up-regulated while Bacl-2 
and COX-2 expressions were down-regulated. 
All these results indicated that the anti-
proliferation effect of PMF on the lung cancer cell 




Apoptosis is a mode of animal cell death which is 
found in normal tissues and tumors. Apoptosis is 
essential for normal cell development and 
disturbance of apoptosis is one of the important 
reasons the development of tumors [12]. In our 
present study, we found that PMF could 
significantly inhibit the proliferation of human 
non-small cell lung cancer (A549 cell) and induce 
cell apoptosis, which suggested that the anti-
proliferation effect might be related to the 
enhancement of apoptosis. 
 
Based on previous researching data, two 
alternative    but    overlapping    pathways    (the 
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Figure 6: Effects of PMF on the protein expressions of caspase-3, caspase-9, Bcl-2, Bax, and COX-2 in A549 
cells. GAPDH was used as the loading control; *p < 0.05, **p < 0.01, compared to the control group 
 
extrinsic and intrinsic pathways) cause cell 
apoptosis [13]. The extrinsic pathway can be 
activated by death receptors while the intrinsic 
pathway can be activated by the release of 
mitochondrial proteins [14,15]. Caspase-8 has 
been demonstrated to play a crucial role in the 
activation of the extrinsic pathway and activated 
caspase-9 is essential for activating the intrinsic 
pathway [13]. Both activated caspase-8 and 
caspase-9 can activate executioner caspases 
like caspase-3 which will activate death 
substrates and lead to cell death [16]. Caspase-3 
is a key executor in the process of apoptosis and 
can hydrolyze specific protein substrates [17]. 
Caspase-3 and caspase-9 expressions are often 
suppressed in various human cancers such as 
lung cancer, breast cancer, prostate cancer [18-
20].  
 
In addition, the Bcl-2 protein family is an 
important regulator of the release of pro-
apoptotic mitochondrial proteins. Bcl-2 is a 
crucial anti-apoptotic protein and Bcl-2 over-
expression contributes to cell survival. The up-
regulation of Bcl-2 expression is found in non-
small-cell lung cancer [22]. Furthermore, Bax is a 
pro-apoptotic member of Bcl-2 family and might 
act on the mitochondrial membrane [22]. 
Importantly, our result showed that PMF could 
enhance caspase-3, caspase-9 and Bax 
expressions while it decreases Bcl-2 expression. 
Thus, we found that PMF induced lung cancer 
cells apoptosis which might be related with 
activation of mitochondria-mediated apoptosis 
pathway. 
 
Furthermore, cyclooxygenase 2 (COX-2) is a key 
enzyme in aberrant arachidonic acid metabolism 
and can catalyze the formation of prostaglandin 
E2 (PGE2) [23]. It has been reported that COX-2/ 
PGE2 can promote lung cancer 
invasion/migration and high expression of COX-2 
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is often found in lung cancer [24]. In addition, 
previous data showed that PGE2activate Bcl-2 
and interleukin-6 (IL-6) which can inhibit cell 
apoptosis and increase cancer cell invasion and 
migration, respectively [25]. In our present study, 
PMF significantly decreased cell invasion and 
migration, and reduced the protein expression 
level of COX-2 in A549 cells, which indicated that 
the inhibitory effect of PMF on lung cancer 
invasion and migration might be associated with 




The findings of this study show that PMF inhibits 
the proliferation, migration and invasion of 
human non-small cell lung cancer A549 cells, 
and also induces cell apoptosis. The mechanism 
may be related to the activation of the intrinsic 
mitochondrion-mediated apoptosis pathway by 
down-regulating the expression of Bcl-2 and up-
regulating the expression of caspase-3, 
casepase-9 and Bax. Furthermore, PMF 
probably influences COX-2 expression and 
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